Roche (RHHBY) Sales, Earnings Grow in 1H24, '24 EPS View Raised

The company reports under two divisions — Pharmaceuticals and Diagnostics. All growth rates mentioned below are on a year-over-year basis and at CER. Sales in the Pharmaceuticals Division improved 5% in the first half to CHF 22.6 billion, driven by strong growth in demand for its key drugs. Roche's shares have risen 6.4% year to date compared with the industry's growth of 20%. Sales of Ocrevus, used to treat two types of multiple sclerosis, increased 8% year over year to CHF 3.3 billion. Second-quarter reve ...